Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(27%)
Results Posted
50%(3 trials)
Terminated
1(9%)

Phase Distribution

Ph early_phase_1
1
9%
Ph not_applicable
10
91%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(6)
Terminated(2)

Detailed Status

Completed6
Active, not recruiting2
Recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
85.7%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

recruiting19%
completed655%
terminated19%
active_not_recruiting218%
withdrawn19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11